newsfilter
← Latest News
Business Wire·

SkinTE® Met Primary and Secondary Endpoints in Final Analysis from Diabetic Foot Ulcer Trial

Data Included in Investigational New Drug Application Submitted on July 23, 2021 Company Announces Completion of Study Evaluating SkinTE for the treatment of Venous Leg Ulcers PolarityTE, Inc. (NASDAQ:PTE) today announced final data from a multi-